Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04099641
Title An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncologie Inc.
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Bavituximab + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.